Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function

被引:34
作者
Kapoor, John R. [1 ]
Heidenreich, Paul A. [1 ,2 ]
机构
[1] Stanford Univ, Div Cardiol, Palo Alto, CA 94304 USA
[2] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
Heart rate; heart failure; mortality; CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; BETA-BLOCKER; SURVIVAL; TRIAL; RISK; ATHEROSCLEROSIS; DYSFUNCTION; PROGRESSION; GUIDELINES;
D O I
10.1016/j.cardfail.2010.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated resting heart rates have been associated with increased mortality and morbidity in patients with heart failure and decreased left ventricular ejection fraction (EF). It is unclear, though, if this association applies to those with heart failure and preserved EF. Methods and Results: We determined outcome for 685 consecutive patients with a prior diagnosis of heart failure and a preserved EF (>50%) documented on echocardiography at 1 of 3 laboratories. Patients with non-sinus rhythm were excluded from the analysis. We determined adjusted mortality rates at 1 year after the echocardiogram. The mean age of the cohort was 70 +/- 11 years. Of the 685 included patients, 87% had a history of hypertension, 50% had diabetes, and the mean EF was 60% +/- 6%. All-cause mortality at 1 year was significantly lower in the group with heart rate below 60 beats/min (10%) when compared with the group with heart rates between 60 and 70 beats/min (18%), 71-90 beats/min (20%), and >90 beats/min (35%) (P<.0001). After adjustment for patient history, demographics, laboratory values, and echocardiographic findings, the hazard ratios for total mortality (relative to a heart rate of <60) were 1.26 (95% CI, 0.88-1.80) for HR 60-69, 1.47 (95% Cl, 1.02-2.07) for HR 70-90, and 2.00 (95% Cl, 1.31-3.04) for HR>90 (P=.01 across all groups). Conclusions: These data suggest that an elevated resting heart rate is a marker for increased mortality in patients with heart failure and preserved systolic function. Heart rate may be useful in these patients for improved cardiovascular risk assessment. (J Cardiac Fail 2010;16:806-811)
引用
收藏
页码:806 / 811
页数:6
相关论文
共 33 条
[11]   Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, P. Gabriel ;
Tendera, Michal ;
Robertson, Michele ;
Ferrari, Roberto .
LANCET, 2008, 372 (9641) :817-821
[12]   Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction:: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study [J].
Fox, Kim ;
Ferrari, Roberto ;
Tendera, Michal ;
Steg, Philippe Gabriel ;
Ford, Ian .
AMERICAN HEART JOURNAL, 2006, 152 (05) :860-866
[13]   What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?: Experiences from the Metoprolol Controlled Release Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF) [J].
Gullestad, L ;
Wikstrand, J ;
Deedwania, P ;
Hjalmarson, Å ;
Egstrup, K ;
Elkayam, U ;
Gottlieb, S ;
Rashkow, A ;
Wedel, H ;
Bermann, G ;
Kjekshus, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) :252-259
[14]   Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness -: Main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS) [J].
Hedblad, B ;
Wikstrand, J ;
Janzon, L ;
Wedel, H ;
Berglund, G .
CIRCULATION, 2001, 103 (13) :1721-1726
[15]   Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption [J].
Heidland, UE ;
Strauer, BE .
CIRCULATION, 2001, 104 (13) :1477-1482
[16]   REFLEX VERSUS TONIC VAGAL ACTIVITY AS A PROGNOSTIC PARAMETER IN PATIENTS WITH SUSTAINED VENTRICULAR-TACHYCARDIA OR VENTRICULAR-FIBRILLATION [J].
HOHNLOSER, SH ;
KLINGENHEBEN, T ;
VANDELOO, A ;
HABLAWETZ, E ;
JUST, H ;
SCHWARTZ, PJ .
CIRCULATION, 1994, 89 (03) :1068-1073
[17]  
Hunt SA, 2005, CIRCULATION, V112, pE154, DOI [10.1161/CIRCULATIONAHA.105.167586, 10.1161/CIRCULATIONAHA.105.167587]
[18]   Heart-rate profile during exercise as a predictor of sudden death [J].
Jouven, X ;
Empana, JP ;
Schwartz, PJ ;
Desnos, M ;
Courbon, D ;
Ducimetière, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1951-1958
[19]  
KJEKSHUS J, 1987, European Heart Journal, V8, P115